insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.
lantus solostar 100 unitsml solution for injection in a pre-filled pen
sanofi-aventis singapore pte. ltd. - insulin glargine - injection, solution - 100 iu/ml - insulin glargine 100 iu/ml
lyxumia solution for injection in pre-filled pen 10mcg (50mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 50mcg/ml - lixisenatide 50mcg/ml
lyxumia solution for injection in pre-filled pen 10mcg and 20mcg (50mcgml and 100mcgml)
sanofi-aventis singapore pte. ltd. - (10mcg) lixisenatide; (20mcg) lixisenatide - injection, solution - 0.05mg/ml - (10mcg) lixisenatide 0.05mg/ml; (20mcg) lixisenatide 0.1mg/ml
lyxumia solution for injection in pre-filled pen 20mcg (100mcgml)
sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 100mcg/ml - lixisenatide 100mcg/ml
zaltrap concentrate for solution for infusion 25 mgml
sanofi-aventis singapore pte. ltd. - aflibercept - infusion, solution concentrate - 25.0 mg/ml - aflibercept 25.0 mg/ml
lantus solostar 100iuml solution for injection in a pre-filled pen
sanofi-aventis (malaysia) sdn. bhd. - insulin glargine -
apidra solostar 100 unitsml solution for injection in a pre-filled pen
sanofi-aventis (malaysia) sdn. bhd. - insulin glulisine -
soliqua solostar 100unitsml+33mcgml solution for injection in a pre-filled pen
sanofi-aventis (malaysia) sdn. bhd. - insulin glargine; lixisenatide -
soliqua solostar 100unitsml+50mcgml solution for injection in a pre-filled pen
sanofi-aventis (malaysia) sdn. bhd. - insulin glargine; lixisenatide -